Free Stock & ETF Comparisons
2300+ side-by-side comparisons with AI scores, valuation metrics, performance charts, analyst targets, and investor takeaways. No sign-in required.
- AI investment scores (0–100) for each stock
- Valuation metrics: P/E, forward P/E, PEG, EV/EBITDA
- Performance charts across 1M to 10Y timeframes
- Analyst price targets and upside estimates
- AI-written investor thesis and side-by-side takeaways
Browse Comparisons
Compare iShares MSCI Brazil ETF and Vanguard FTSE Emerging Markets ETF by Brazil commodity cycle leverage, China concentration risk in VWO, political risk, and total return history.
Compare Grab Holdings' publicly traded investment thesis vs Gojek's (GoTo Group) strategy in Indonesia by market share in key verticals, fintech monetisation, and path to profitability.
Compare TD Bank and Royal Bank of Canada by US consumer banking presence, capital markets revenue, AML regulatory overhang (TD), dividend yield, and which Big Five Canadian bank is the safer ADR.
Compare Moderna and Recursion Pharmaceuticals by mRNA oncology pipeline vs AI-driven drug discovery platform, clinical-stage pipeline diversity, cash runway, and which next-generation biotech platform creates more long-term value.
Compare Regeneron and Vertex Pharmaceuticals by Eylea/Dupixent commercial durability, Trikafta CFTR sales, R&D pipeline depth, and which large-cap biotech has more durable long-term earnings power.
Compare Biogen and Gilead Sciences by Leqembi Alzheimer's commercial ramp, Biktarvy HIV franchise durability, oncology cell therapy pipeline, and which mid-to-large biotech offers better risk-adjusted upside.
Compare Alnylam and Ionis Pharmaceuticals by siRNA platform royalty stack, antisense oligonucleotide licensing revenue, Inclisiran commercial growth, and which nucleic acid medicine platform is better positioned.
Compare CRISPR Therapeutics and Editas Medicine by exa-cel sickle cell commercial launch, CRISPR delivery modality, patent position, cash runway, and which gene editing stock is the better speculation.
Compare Intellia Therapeutics and CRISPR Therapeutics by in-vivo liver delivery vs ex-vivo stem cell editing, transthyretin amyloidosis program, cash position, and clinical milestone catalysts.
Compare Exact Sciences and GoodRx by Cologuard screening revenue growth, GoodRx pharmacy network monetisation, gross margin trajectory, and which healthcare tech platform is the better recovery story.
Compare ACM Research and Onto Innovation by China revenue exposure, advanced packaging and inspection TAM, semiconductor equipment cycle positioning, and which small-cap equipment stock has more upside.
Compare Halozyme Therapeutics and ACADIA Pharmaceuticals by ENHANZE royalty stream growth, Daybue Rett syndrome commercial launch, pipeline risk, and which specialty pharma has more predictable revenue.
Compare Gilead Sciences and Merck by Biktarvy HIV franchise durability, Keytruda immuno-oncology patent cliff risk, HIV prevention lenacapavir launch, HPV vaccine market share, and which large pharma is better valued.
Compare Enphase Energy and SolarEdge Technologies by residential solar market share, battery storage attach rate, Europe headwind, gross margin compression, and which solar inverter company recovers fastest.
Compare First Solar and Canadian Solar by CadTel vs polysilicon technology, US IRA manufacturing credit, utility-scale project backlog, and which solar module maker benefits from tariff protection.
Compare Sunrun and Sunnova Energy by subscriber growth, net present value per system, battery attachment rate, customer acquisition cost, and residential solar financing risk.
Compare Stem and NextEra Energy by grid battery storage software ARR, utility-scale wind/solar pipeline, IRA credit monetisation, and which clean energy platform is better positioned through 2030.
Compare Clearway Energy and Brookfield Renewable Partners by contracted cash flow visibility, dividend growth commitment, asset portfolio diversification, and which renewable yieldco offers more stable income.
Compare AES Corporation and Dominion Energy by renewable energy mix, regulated utility earnings stability, clean energy capex plan, dividend safety, and which utility is further along in decarbonisation.
Compare Eve Air Mobility and Joby Aviation by FAA certification progress, aircraft manufacturing plan, airline partner agreements, cash runway, and which electric air taxi company is closer to commercial launch.
Compare Archer Aviation and Wisk Aero by piloted vs autonomous eVTOL certification path, Midnight aircraft manufacturing plan, Boeing-backed Wisk development timeline, and which electric air taxi company reaches revenue first.
Compare Orsted and NextEra Energy by offshore wind project pipeline, US IRA incentive capture, contract renegotiation headwinds, and which renewable energy ADR is more attractive for ESG investors.
Compare Block (Square) and Toast by SMB payment volume growth, restaurant vertical software ARPU, gross profit margin trajectory, seller vs restaurant customer LTV, and fintech platform upsell.
Compare Affirm and Sezzle by GMV growth, interest income yield, merchant network size, delinquency rates, regulatory risk, and which buy-now-pay-later platform has more durable unit economics.
Compare SoFi Technologies and LendingClub by bank charter benefits, personal loan origination quality, student loan refinancing recovery, deposit growth, and which digital lending fintech wins the next credit cycle.
Compare Upstart and OpenLending by auto loan vs lenders protection AI model revenue, bank/credit union partner count, fee income vs interest income mix, and which AI credit marketplace rebounds faster in a rate-easing cycle.
Compare Nu Holdings and Wise by consumer banking ARPU in Brazil/Mexico, cross-border remittance fee disruption, geographic expansion strategy, and which international fintech platform is the better high-growth investment.
Compare WEX and Fleetcor (Corpay) by fleet card processing volume, corporate travel payment recovery, healthcare payment ARR, and which B2B specialty payment processor is better valued.
Compare Comerica and PNC Financial by commercial banking NIM sensitivity to rates, Texas/Midwest geographic concentration, fee income diversification, and dividend yield.
Compare Regions Financial and Huntington Bancshares by Southeast vs Great Lakes loan book quality, commercial real estate exposure, net interest margin compression, and which regional bank is more resilient.
Compare Colgate-Palmolive and Procter & Gamble by oral care market share, premium product mix, emerging market exposure, pricing power during inflation, dividend growth, and long-term compounder value.
Compare Conagra Brands and J.M. Smucker by frozen food portfolio share gain, Twinkies/Hostess integration, pet food business, private label competition, and dividend yield for consumer staples investors.
Compare General Mills and Hormel Foods by Blue Buffalo pet food growth vs Spam/Planters protein brands, private label pressure, dividend growth streak, and which consumer staples compounder is better in a recessionary environment.
Compare Kraft Heinz and Conagra Brands by brand portfolio revitalisation pace, cost savings program execution, grocery private label share loss, debt load, and dividend safety.
Compare McDonald's and Wendy's by global same-store sales growth, digital loyalty ARPU, franchise remodel capex program, and which fast food chain commands a better long-term unit economics model.
Compare Yum! Brands and Restaurant Brands International by Pizza Hut/KFC/Taco Bell vs Popeyes/BK/Tim Hortons system growth, digital penetration, emerging market unit expansion, and franchisor dividend yield.
Compare Dollar Tree and Five Below by store traffic trends after $1.25 transition, teen discretionary spending cycle, price point elasticity, and which value retailer recovers stronger.
Compare Under Armour and Lululemon by brand repositioning vs premium athleisure retention, North American vs international growth, gross margin gap, and which athletic apparel company has the more compelling recovery story.
Compare Twilio's messaging and voice API revenue growth, customer data platform (Segment) synergies, margin improvement trajectory, and competitive position against AWS Connect and Google CCAI.
Compare DocuSign and Box by eSignature market share defensibility against Adobe Sign, intelligent agreement management AI launch, Box AI enterprise content revenue, and which document SaaS is a better recovery story.
Compare Autodesk and PTC by AEC/manufacturing subscription ARR, Windchill PLM vs BIM 360 construction growth, AI generative design adoption, and which industrial software company benefits most from manufacturing reshoring.
Compare Braze and Twilio by multi-channel customer engagement ARR, AI-powered send-time optimization, net revenue retention, enterprise deal size, and which marketing technology platform compounds faster.
Compare Sprinklr and Salesforce's social/CXM layer by unified customer experience management ARR, enterprise contract size, AI sentiment analysis, and which customer experience platform is a better standalone bet.
Compare Appian and Pegasystems by government vs commercial low-code platform ARR, AI process automation (BPMS) revenue, cloud subscription transition pace, and which process automation SaaS is better valued.
Compare Datadog and Sumo Logic by multi-cloud observability ARR, AI-powered log analytics, security analytics upsell, net revenue retention, and which cloud monitoring platform is more defensible at enterprise scale.
Compare Dynatrace and Datadog by AI-causal analysis vs metric aggregation approach, AIOps automation revenue, enterprise vs SMB customer mix, multi-cloud coverage, and gross margin.
Compare GitLab and Asana by DevSecOps all-in-one platform ARR, AI code assistant (GitLab Duo) adoption, enterprise seat expansion, and which enterprise software stock has a more compelling path to profitability.
Compare Confluent and MongoDB by Kafka-as-a-Service cloud revenue, Atlas multi-cloud database ARR, AI/ML workload data platform demand, and which developer data infrastructure company compounds faster.
Sign in to access the full platform — compare any stocks, build watchlists, and get AI-powered portfolio insights.
Start Free Trial